Calendar

pharmadog

Date TBD

TBDapprovalOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

full page →dexamethasone LA →fda approvals ↗

TBDapprovalTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →OXCARBAZEPINE →fda approvals ↗

RECRUITINGphase readoutNCT06924671: GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain

full page →ctgov ↗

COMPLETEDphase readoutNCT07542236: Hip and Ankle Mobility Rehabilitation for Soccer Players With Patellofemoral Pain

Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)Definium Therapeutics, Inc.

Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder

full page →ctgov ↗

RECRUITINGphase readoutNCT06466434: Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma

full page →ctgov ↗

RECRUITINGphase readoutNCT06806709: Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection

full page →ctgov ↗

RECRUITINGphase readoutNCT07178509: A Study of SCAD Using Stress Contrast EchocardiographyMayo Clinic

Sponsor: Mayo Clinic. Phase: . Conditions: Spontaneous Coronary Artery Dissection

full page →ctgov ↗

COMPLETEDphase readoutNCT07403409: Scapular Repeated Contractions Facilitation Versus Hold-relax Techniques in Patients With Adhesive Capsulitis

Sponsor: Riphah International University. Phase: NA. Conditions: Adhesive Capsulitis of the Shoulder

full page →ctgov ↗

COMPLETEDphase readoutNCT06721663: Multisensory Environment Stimulation Therapy on Postural Control in Cerebral Palsy

Sponsor: October 6 University. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06624787: Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care

Sponsor: Liverpool School of Tropical Medicine. Phase: NA. Conditions: Crimean-Congo Haemorrhagic Fever

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07527221: Safety and Tolerability of ZE74-0282 in Healthy VolunteersCerta Therapeutics Pty Ltd

Sponsor: Eilean Therapeutics AU Pty Ltd. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗

RECRUITINGphase readoutNCT07329114: Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)

Sponsor: Chandan Sen. Phase: NA. Conditions: Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections

full page →ctgov ↗

RECRUITINGphase readoutNCT01778504: Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Neuropsychiatric Disorder, Neurological Disorder, Neurodevelopmental Disorder, Sleep

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05103033: Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)University of Washington

Sponsor: University of Washington. Phase: NA. Conditions: Mental Health Disorder

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT06906952: A Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon Cancer

Sponsor: Nanchang University. Phase: NA. Conditions: Natural Orifice Specimen Extraction Surgery, Robotic Surgery, Short-term Outcomes

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07281547: Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and PainMayo Clinic

Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Endometrial Carcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07442149: An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005ALUMIS INC.

Sponsor: Alumis Inc. Phase: PHASE1. Conditions: Healthy Volunteer

full page →ctgov ↗

COMPLETEDphase readoutNCT07418138: Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

Sponsor: Hu Liangshuo. Phase: . Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC), Tyrosine Kinase Inhibitor, Survival Rate

full page →ctgov ↗

RECRUITINGphase readoutNCT07362238: Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Immune Thrombocytopenia, Treatment

full page →ctgov ↗

TERMINATEDphase readoutNCT04221438: Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node InvolvementArray BioPharma Inc

Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Recurrent Cutaneous Melanoma

full page →ctgov ↗

COMPLETEDphase readoutNCT04461158: CCCR Lupus Patient Navigator Program

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Systemic Lupus Erythematosus (SLE)

full page →ctgov ↗

RECRUITINGphase readoutNCT07307248: To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

Sponsor: Asian Institute of Gastroenterology, India. Phase: NA. Conditions: Walled Off Necrosis

full page →ctgov ↗

COMPLETEDphase readoutNCT06877026: FibroScan-Reproducibility and Repeatability Study

Sponsor: Echosens. Phase: NA. Conditions: Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related

full page →ctgov ↗

RECRUITINGphase readoutNCT07418385: Voluntary HIV Screening in the General Population in France

Sponsor: Université de Reims Champagne-Ardenne. Phase: . Conditions: Human Immunodeficiency Virus (HIV)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03078543: Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee SystemSMITH & NEPHEW PLC

Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthroplasty, Replacement, Knee

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07480343: 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

Sponsor: Iantrek, Inc.. Phase: . Conditions: Open-angle Glaucoma (OAG)

full page →ctgov ↗

RECRUITINGphase readoutNCT07550543: PEMF Therapy in Shoulder Tendinopathy

Sponsor: Balnear and Rehabilitation Sanatorium Techirghiol. Phase: NA. Conditions: Shoulder Tendinopathy

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07298408: Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot StudyJazz Pharmaceuticals plc

Sponsor: Florida A&M University. Phase: PHASE1. Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07422025: Prognostic Value of Preoperative Frailty Assessment in Geriatric Lower Limb Orthopedic Surgery

Sponsor: Benha University. Phase: . Conditions: Lower Limb Fracture

full page →ctgov ↗

RECRUITINGphase readoutNCT07414576: AI-driven Total Parenteral Nutrition Platform

Sponsor: Takeoff41, Inc.. Phase: NA. Conditions: Intestinal Failure

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05003817: Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular UnloadingGuy's and St Thomas' NHS Foundation Trust

Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: PHASE3. Conditions: Ischemic Heart Disease, Coronary Artery Disease

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07450040: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell LymphomaContinuity Biosciences LLC

Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: ORR, OS, PFS

full page →ctgov ↗

RECRUITINGphase readoutNCT02280889: Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

Sponsor: University Children's Hospital, Zurich. Phase: . Conditions: Quality of Life, Stigmatization

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07463768: Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.Bristol-Myers Squibb Co

Sponsor: French Innovative Leukemia Organisation. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Sponsor: Medtronic Cardiovascular. Phase: . Conditions: Aortic Stenosis

full page →ctgov ↗

RECRUITINGphase readoutNCT05316571: Sitting Interruption and Whole-body Cardiovascular Health

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Sedentary Behavior, Sedentary Time

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05537064: Centralized Prescribing for StatinsUniversity of Pennsylvania

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Hyperlipidemias

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07524764: Female Reproductive Health in Canadian Armed Forces

Sponsor: Université de Sherbrooke. Phase: . Conditions: Pregnancy, Pelvic Floor Dysfunction, Military Personnel, Contraception, Infertility, Women's Health

full page →ctgov ↗

COMPLETEDphase readoutNCT04602598: Zanubrutinib in Patients With IgG4-Related DiseaseBeOne Medicines Ltd.

Sponsor: Matthew C. Baker. Phase: PHASE2. Conditions: IgG4 Related Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT05470998: L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

Sponsor: Tanta University. Phase: PHASE3. Conditions: Sickle Cell Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT06778863: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationC4 Therapeutics, Inc.

Sponsor: Clasp Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumor, Unresectable Solid Tumor, Metastatic Solid Tumor, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma, Prostate Cancer, Bladder Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT05289687: Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLJOHNSON & JOHNSON

Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia

full page →ctgov ↗

COMPLETEDphase readoutNCT07416487: Comparison of Outcome of Foley Catheter Versus Misoprostol for Induction of LaborAFYX Therapeutics A/S

Sponsor: Muhammad Aamir Latif. Phase: NA. Conditions: Labor

full page →ctgov ↗

COMPLETEDphase readoutNCT05064293: Assisted Identification and Navigation of Early Mental Health Symptoms in Children

Sponsor: Kaiser Permanente. Phase: NA. Conditions: Adolescent Behavior, Mental Health Issue

full page →ctgov ↗

RECRUITINGphase readoutNCT06896916: Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaAbbVie Inc.

Sponsor: AbbVie. Phase: PHASE1. Conditions: Multiple Myeloma

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06472284: TetraGraph in Rocuronium Infusions

Sponsor: Joseph D. Tobias. Phase: NA. Conditions: Surgery

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04849884: To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System.SMITH & NEPHEW PLC

Sponsor: Smith & Nephew, Inc.. Phase: NA. Conditions: Arthroplasty, Replacement, Knee

full page →ctgov ↗

RECRUITINGphase readoutNCT07544784: AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)

Sponsor: Fudan University. Phase: PHASE2. Conditions: Colorectal Cancer Liver Metastases (CRLM)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07197684: Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer SurgeryNRX Pharmaceuticals, Inc.

Sponsor: Aga Khan University. Phase: NA. Conditions: Breast Cancer, Pain, Chronic, Post Surgical Pain

full page →ctgov ↗

Date TBD